Halda Therapeutics Receives FDA Fast Track Designation for HLD-0915 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Ask Yale Ventures: What Does Innovation Look Like in the Creative and Cultural Space? 11/13/2025 12:00PM—1:00PM